Pfizer purchased companies that produce drugs to treat the same conditions caused by covid vaccines
By Rhoda Wilson on July 2, 2024 •
In 2017 a former vice president of Pfizer blew the whistle and said that pharmaceutical companies intentionally design vaccines to keep the public in a state of illness to profit from the treatments of vaccine-induced illnesses.
Pfizer’s acquisitions of other pharmaceutical companies since the rollout of its covid vaccine seem to indicate this is indeed the case.
In 2021, Pfizer’s acquisition of Arena Pharmaceuticals raised eyebrows. The purchase price seemed disproportionate to the market size of the drug they acquired – a drug that is a potential therapy for all kinds of immuno-inflammatory diseases, including inflammation of the heart. As we know, myocarditis began to skyrocket after the rollout of Pfizer’s mRNA vaccines.
In 2023, Pfizer purchased Seagen Pharmaceuticals, known for its cancer drugs. Was this because of the connection between the mRNA injections and “turbo cancers”?
In 2022, Pfizer purchased Global Blood Therapeutics for its drug to treat sickle cell disease, again for an amount that seemed disproportionate to the profit the company could make off the drug considering how many people have the disease. Does Pfizer know something we don’t? Will we see a blood cell disease epidemic as well?
Continued at link